Clinical trial

A Dose Escalation Phase I Study of PDC-1421 Capsule Targeting in Depression

NCT01774045

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-11-01

PhasePHASE1

Study timeline

Study start (unknown)2012-11-01Date precision: month

Registry last updated2020-08-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Major Depressive Disorderunresolved

Interventions

PDC-1421DRUG

PlaceboDRUG

Sponsors & collaborators

BioLite, Inc.lead sponsor

Mapped research locations

TaipeiTaiwan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01774045 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.